Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|January 11, 2024
Treatment patterns of patients with HR+/HER2- metastatic breast cancer receiving CDK4/6 inhibitor-based regimens: a cohort study in the French nationwide healthcare databaseStephanie H Read, Nadia Quignot, Raissa Kapso-Kapnang, et al.
Journal of Managed Care & Specialty Pharmacy|August 5, 2021
Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinomaEleanor Paul, Gerasimos Konidaris, Shannon Cope, et al.
Pediatric Blood & Cancer|April 12, 2018
Epidemiologic and clinical characteristics of nontransfusion-dependent thalassemia in the United StatesElliott Vichinsky, Alan Cohen, Alexis A Thompson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2021
Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness AnalysisGerasimos Konidaris, Eleanor Paul, Andreas Kuznik, et al.
Clinical and Translational Science|February 24, 2026
Best Practices and Gaps in Current Regulatory and Health Technology Assessment Real-World Evidence Policies for Medicines and Medical Devices: Current State of Play and Next StepsKatharine Cresswell, Ravinder Claire, Laila Issa, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Characteristics, treatment patterns, and survival among ALK+ non-small cell lung cancer (NSCLC) patients treated with crizotinib: A chart review studyJacques Cadranel, Keunchil Park, Oscar Arrieta, et al.
Breast (Edinburgh, Scotland)|July 23, 2022
Progression-free survival and quality of life in metastatic breast cancer: The patient perspectiveShirley Mertz, Christine Benjamin, Charis Girvalaki, et al.
JCO Precision Oncology|February 1, 2022
Economic Impact of Next-Generation Sequencing Versus Single-Gene Testing to Detect Genomic Alterations in Metastatic Non-Small-Cell Lung Cancer Using a Decision Analytic ModelNathan A Pennell, Alex Mutebi, Zheng-Yi Zhou, et al.
Future Oncology (London, England)|January 18, 2020
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinomaMichael R Migden, Sunandana Chandra, Guilherme Rabinowits, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Real-world treatment patterns and survival of patients with BRAF V600-mutated metastatic non-small cell lung cancerLeora Horn, Joshua Bauml, Patrick M Forde, et al.
Pageof 5